Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9626 posts found.

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010 Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Appointment

Sanofi extends Genzyme share deal deadline

December 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010 Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010 Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
News

China to ‘overtake US in innovation by 2020’

December 13, 2010 Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
News

Bristol-Myers Squibb appoints new UK general manager

December 13, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing

Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
News

Pfizer: WikiLeaks claims “preposterous”

December 10, 2010 Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …
News

Hormone therapy drugs ‘increase heart disease risk’

December 10, 2010 Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen

Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …
News

Elan names Robert Ingram as new chairman

December 10, 2010 Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
Appointment

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010 Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …
News

Roche highlights R&D promise after setbacks

December 9, 2010 Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …
News

William Vickery joins Hybrigenics

December 8, 2010 Research and Development Hybrigenics, William Vickery, appointment, research and development

Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …
Appointment

Astellas signs stem cell partnership in liver disease

December 8, 2010 Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine

Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …
News

Out-of-hour procedures for clinical trials

December 8, 2010 Research and Development GCP, Good Clinical Practice, Guy’s and St Thomas’ NHS Foundation Trust, Katherine Kennedy, clinical trials, trial safety

When a clinical trial subject is involved in a medical emergency, the hospital team need rapid access to information about …
Feature

Contract research news in brief

December 8, 2010 Research and Development Cell Trends, Laboratory Corporation of America, PPD, Parexel, Patheon, Quintiles, Texcell, Unithink, contract research, contract research organisations

Our round-up of recent development in the contract research sector includes updates from Patheon, Parexel, PPD, Quintiles, Unithink, Texcell and …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026